6 news items
Biotech Companies Making Strides in Pancreatic Cancer Treatment and Early Detection
ABVC
AMGN
CADL
15 May 24
) in pancreatic cancer in a new cohort from its ongoing GOBLET study, following German regulatory and ethics approvals. The new cohort is bolstered
Biotech Companies Making Strides in Pancreatic Cancer Treatment and Early Detection
ABVC
AMGN
CADL
15 May 24
Roche) in pancreatic cancer in a new cohort from its ongoing GOBLET study, following German regulatory and ethics approvals. The new cohort
Biotech Innovations Surge as Global Cancer Diagnosis Rates Continue to Climb
AZN
CADL
HALO
9 May 24
in a new cohort for its ongoing GOBLET study, following German regulatory and ethics approvals.
The new cohort
Biotech Innovations Surge as Global Cancer Diagnosis Rates Continue to Climb
AZN
CADL
HALO
9 May 24
in a new cohort for its ongoing GOBLET study, following German regulatory and ethics approvals.
The new
Biotech Innovations Surge as Global Cancer Diagnosis Rates Continue to Climb
AZN
CADL
HALO
9 May 24
study, following German regulatory and ethics approvals.
The new cohort is also being supported
085m8o6tjdx1q3ydiwru906ox7hhaeowg 91tdmls248uo6
AZN
CADL
HALO
9 May 24
, following German regulatory and ethics approvals.
The new cohort is also being supported
- Prev
- 1
- Next